{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Henry+Smith&AnsweringBody.=Department+of+Health+and+Social+Care&max-date=2023-11-17", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?tablingMember.label=Biography+information+for+Henry+Smith&AnsweringBody.=Department+of+Health+and+Social+Care&max-date=2023-11-17", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Henry+Smith&AnsweringBody.=Department+of+Health+and+Social+Care&max-date=2023-11-17&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Henry+Smith&_page=0&AnsweringBody.=Department+of+Health+and+Social+Care&max-date=2023-11-17", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Henry+Smith&AnsweringBody.=Department+of+Health+and+Social+Care&max-date=2023-11-17", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Henry+Smith&AnsweringBody.=Department+of+Health+and+Social+Care&max-date=2023-11-17", "items" : [{"_about" : "http://data.parliament.uk/resources/1670746", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1670746/answer", "answerText" : {"_value" : "

The Government is committed to supporting rapid patient access to effective new medicines in a way that is fair to all parties and represents value to the National Health Service. The National Institute for Health and Care Excellence (NICE) plays an important role in supporting patient access to effective new medicines and is able to recommend most new medicines for use in the NHS. Where there is too much clinical uncertainty for NICE to be able to recommend routine funding, it is able to recommend medicines for use through the Cancer Drugs Fund or Innovative Medicines Fund which make promising medicines available to patients while further real-world evidence is collected to inform a final NICE recommendation.<\/p>

NICE is responsible for the methods and processes it uses in the evaluation of new medicines and the changes that it has recently made to its evaluation processes will enable it to produce faster guidance on simpler, low-risk treatments. NICE and NHS England are exploring options for rapid entry to managed access (REMA) that build on the experience of the Cancer Drugs Fund and Innovative Medicines Fund to support managed access to medicines. NICE has not yet made any changes to its health technology evaluation manual related to REMA.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2023-11-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-11-22T15:53:14.497Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-11-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of (a) updates to the programme manual used by the National Institute of Health and Care Excellence including Rapid Access to Managed Access and (b) the introduction of the Innovative Medicines Fund.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "2397"} , {"_about" : "http://data.parliament.uk/resources/1669201", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1669201/answer", "answerText" : {"_value" : "

The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service in England on whether all new licensed medicines represent a clinically effective and cost-effective use of NHS resources. NICE has been able to recommend several gene therapies for routine funding and they are now routinely available to NHS patients in line with NICE\u2019s recommendations. No gene therapies have been recommended for use through the Innovative Medicines Fund and NICE continues to consider the suitability of medicines for the Fund with individual companies.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"} } , "answeringMemberConstituency" : {"_value" : "Pendle"} , "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"} , "dateOfAnswer" : {"_value" : "2023-11-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-11-16T17:26:10.777Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-11-10", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Innovative Medicines Fund: Gene Therapies"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the Innovative Medicines Fund in increasing access to gene therapies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "1326"} , {"_about" : "http://data.parliament.uk/resources/1665400", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1665400/answer", "answerText" : {"_value" : "

NHS England has developed a new fast-track echocardiography training scheme, which has led to 150 additional echocardiographers with further support being available in 2023/24.<\/p>

More generally, the NHS People Plan and the People Promise set out a comprehensive range of actions to improve staff retention. They provide a strong focus on creating a more modern, compassionate and inclusive culture in the National Health Service by strengthening health and wellbeing, equality and diversity, culture and leadership and flexible working.<\/p>

<\/p>

NHS priorities and operational planning guidance 23/24 has asked systems to refresh their 2022/23 whole system workforce plans to improve staff retention through a systematic focus on all elements of the NHS People Promise.\u202f Staff wellbeing should be strategically aligned\u202fwith elective recovery plans, including workforce\u202fdemand and capacity planning.\u202f\u202fIn addition, the NHS Retention Programme is continuously seeking to understand why staff leave, resulting in targeted interventions to support staff to stay whilst keeping them well.<\/p>

<\/p>

The Long Term Workforce Plan builds on the People Plan and sets out how to improve culture and leadership to ensure that up to 130,000 fewer staff leave the NHS over the next 15 years. This includes: implementing actions from the NHS People Plan that have been shown to be successful; and implementing plans to improve flexible opportunities for prospective retirees and delivering the actions needed to modernise the NHS pension scheme.<\/p>

<\/p>

These interventions apply across staff groups, including echocardiographers.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-10-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-10-20T09:37:50.89Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-10-17", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Heart Diseases: Health Services"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the recommendations of the British Society for Echocardiography made in its report entitled The UK Echocardiography Workforce published in June 2023, whether his Department is taking steps to help ensure that the NHS retains a sufficient number of experienced echocardiographers to train new recruits.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "202955"} , {"_about" : "http://data.parliament.uk/resources/1658372", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1658372/answer", "answerText" : {"_value" : "

Data on radiotherapy linear accelerator (LINAC) machines is not held at constituency level. Since April 2022, the responsibility for investing in new radiotherapy machines sits with local systems. This is supported by the 2021 Spending Review, which set aside £12 billion in operational capital for the National Health Service between 2022 and 2025.<\/p>

Recent Capital Planning Guidance sets out the expectation that the majority of radiotherapy equipment, particularly LINAC machines, will need to be replaced at ten years of age, to make progress on Long Term Plan priorities. The guidance states that integrated care systems (ICSs) need to develop replacement plans as part of their multi-year capital plans, in partnership with specialised commissioners, Cancer Alliances and Radiotherapy Operational Delivery Networks, based on an assessment of equipment age, capacity and demand, opportunities to improve access, and service risk.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-09-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-12T14:57:36.46Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Radiotherapy: Crawley"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many radiotherapy LINAC machines will be over the recommended 10-year lifespan by the end of (a) 2023, (b) 2024, and (c) 2025 in Crawley constituency.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "197766"} , {"_about" : "http://data.parliament.uk/resources/1658373", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1658373/answer", "answerText" : {"_value" : "

NHS England\u2019s National Moderation Panel will determine how many integrated care boards (ICBs) will take on responsibility for specialised commissioning in October 2023. Following this moderation process, recommendations will be taken to the NHS England Board for final decisions in December 2023, before new arrangements go live from April 2024.<\/p>

This process will consider the delegation of radiotherapy commissioning for ICBs across England including across the Crawley constituency.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} , "dateOfAnswer" : {"_value" : "2023-09-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-12T13:49:15.247Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Radiotherapy"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he plans to devolve any aspect of radiotherapy commissioning to integrated care boards in (a) Crawley constituency and (b) England; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "197767"} , {"_about" : "http://data.parliament.uk/resources/1655923", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1655923/answer", "answerText" : {"_value" : "

The Government has agreed to provide funding of £1 million to design a grant scheme for the expansion of automated external defibrillators (AEDs) that expands the number and accessibility of publicly supported access to defibrillators.<\/p>

Applicants will be asked to demonstrate that defibrillators will be placed in areas where they are most needed, such as places with high footfall, longer emergency medical response times and deprived areas<\/p>


No assessment has been made of the potential fiscal impact of increasing the number of AEDs available to the public on healthcare services. The number of instances of sudden cardiac arrest that have occurred outside of hospitals in the last five years is not available centrally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-09-06", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "196007"} , {"_value" : "196008"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-06T15:51:09.86Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Defibrillators"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to help reduce economic barriers to accessing defibrillators.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "196006"} , {"_about" : "http://data.parliament.uk/resources/1655924", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1655924/answer", "answerText" : {"_value" : "

The Government has agreed to provide funding of £1 million to design a grant scheme for the expansion of automated external defibrillators (AEDs) that expands the number and accessibility of publicly supported access to defibrillators.<\/p>

Applicants will be asked to demonstrate that defibrillators will be placed in areas where they are most needed, such as places with high footfall, longer emergency medical response times and deprived areas<\/p>


No assessment has been made of the potential fiscal impact of increasing the number of AEDs available to the public on healthcare services. The number of instances of sudden cardiac arrest that have occurred outside of hospitals in the last five years is not available centrally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-09-06", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "196006"} , {"_value" : "196008"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-06T15:51:09.893Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Defibrillators"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential fiscal impact of increasing the number of Automated External Defibrillators available to the public on healthcare services.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "196007"} , {"_about" : "http://data.parliament.uk/resources/1655925", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1655925/answer", "answerText" : {"_value" : "

The Government has agreed to provide funding of £1 million to design a grant scheme for the expansion of automated external defibrillators (AEDs) that expands the number and accessibility of publicly supported access to defibrillators.<\/p>

Applicants will be asked to demonstrate that defibrillators will be placed in areas where they are most needed, such as places with high footfall, longer emergency medical response times and deprived areas<\/p>


No assessment has been made of the potential fiscal impact of increasing the number of AEDs available to the public on healthcare services. The number of instances of sudden cardiac arrest that have occurred outside of hospitals in the last five years is not available centrally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-09-06", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "196006"} , {"_value" : "196007"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-06T15:51:09.8Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-01", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Heart Diseases"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many instances of sudden cardiac arrest have occurred outside of hospitals in the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "196008"} , {"_about" : "http://data.parliament.uk/resources/1643069", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1643069/answer", "answerText" : {"_value" : "

The Secretary of State for Health and Social Care meets regularly with other Cabinet colleagues and with NHS England to discuss issues relating to the National Health Service workforce.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} , "dateOfAnswer" : {"_value" : "2023-06-14", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-06-14T14:00:35.56Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-06-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cancer and Radiology"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he has made recent representations made to (a) the Chancellor of the Exchequer and (b) NHS England on investment in the clinical (i) radiology and (ii) oncology workforce.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "188505"} , {"_about" : "http://data.parliament.uk/resources/1628301", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1628301/answer", "answerText" : {"_value" : "

The National Institute of Health and Care Excellence (NICE) recently carried out a comprehensive review of its methods and processes for health technology evaluation to ensure that they were appropriate to emerging new technologies such as advanced therapeutic medicinal products (ATMPs). NICE published its updated health technology evaluation manual in January 2022 and has introduced a number of changes that ensure that its appraisal processes are suitable for emerging new medicines, including a broader severity modifier and changes to better respond to uncertainty. There are no plans for a further assessment of NICE\u2019s processes for evaluating ATMPs.<\/p>

<\/p>

NICE\u2019s methods and processes have been proven to be suitable for ATMPs where companies are willing to price their products in a way that represents value to the taxpayer. NICE has recommended 80% of the ATMPs it has evaluated for use by the National Health Service and they are now available for the treatment of NHS patients, including through the Cancer Drugs Fund and managed access agreements negotiated between the NHS and the manufacturer.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-05-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-05-25T12:35:12.837Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-05-16", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Advanced Therapy Medicinal Products"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of reviewing the way the National Institute for Health and Care Excellence and NHS England evaluate and adopt Advanced Therapy Medicinal Products as technologies with the potential to deliver significant health gains over long periods of time.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3960", "label" : {"_value" : "Biography information for Henry Smith"} } , "tablingMemberConstituency" : {"_value" : "Crawley"} , "tablingMemberPrinted" : [{"_value" : "Henry Smith"} ], "uin" : "185240"} ], "itemsPerPage" : 10, "next" : "http://eldaddp.azurewebsites.net/answeredquestions.text?tablingMember.label=Biography+information+for+Henry+Smith&_page=1&AnsweringBody.=Department+of+Health+and+Social+Care&max-date=2023-11-17", "page" : 0, "startIndex" : 1, "totalResults" : 229, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }